Entry |
|
Name |
Polmacoxib (USAN/INN) |
Formula |
C18H16FNO4S
|
Exact mass |
361.0784
|
Mol weight |
361.39
|
Structure |

|
Class |
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01922 Selective COX2 inhibitor
DG01907 Anti-inflammatory drug, coxibs
|
Remark |
|
Efficacy |
Anti-inflammatory, COX-2 inhibitor |
Target |
|
Pathway |
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
M01AH Coxibs
M01AH07 Polmacoxib
D10656 Polmacoxib (USAN/INN)
Drug groups [BR:br08330]
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01922 Selective COX2 inhibitor
DG01907 Anti-inflammatory drug, coxibs
D10656 Polmacoxib
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Prostaglandin synthase
PTGS2 (COX2)
D10656 Polmacoxib (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 25
1 C1z C 24.5700 -16.6600
2 O2x O 23.7300 -15.5400
3 C2y C 22.4000 -15.9600
4 C2y C 22.4000 -17.3600
5 C5x C 23.7300 -17.7800
6 O5x O 24.2900 -19.3200
7 C8x C 18.7600 -18.0600
8 C8x C 18.7600 -19.4600
9 C8y C 19.9500 -20.1600
10 C8x C 21.2100 -19.4600
11 C8y C 21.2100 -18.0600
12 C8x C 19.9500 -17.3600
13 C8y C 18.7600 -13.8600
14 C8x C 18.7600 -15.2600
15 C8x C 19.9500 -15.9600
16 C8y C 21.2100 -15.2600
17 C8x C 21.2100 -13.8600
18 C8x C 19.9500 -13.1600
19 S4a S 17.5700 -13.1600
20 O3c O 18.2700 -11.9700
21 O3c O 16.8700 -14.4200
22 N1a N 16.3100 -12.4600
23 C1a C 25.6200 -15.8200
24 C1a C 25.7600 -17.3600
25 X F 19.9500 -21.5600
BOND 27
1 1 2 1
2 2 3 1
3 3 4 2
4 4 5 1
5 1 5 1
6 5 6 2
7 7 8 2
8 8 9 1
9 9 10 2
10 10 11 1
11 11 12 2
12 7 12 1
13 11 4 1
14 13 14 2
15 14 15 1
16 15 16 2
17 16 17 1
18 17 18 2
19 13 18 1
20 16 3 1
21 13 19 1
22 19 20 2
23 19 21 2
24 19 22 1
25 1 23 1
26 1 24 1
27 9 25 1
|